IRIS
SARNELLI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.176
NA - Nord America 9.570
EU - Europa 8.096
SA - Sud America 1.249
AF - Africa 296
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 11
Totale 30.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.123
SG - Singapore 4.767
RU - Federazione Russa 3.030
CN - Cina 2.103
IT - Italia 1.992
VN - Vietnam 1.962
BR - Brasile 1.012
HK - Hong Kong 882
DE - Germania 585
FR - Francia 484
FI - Finlandia 346
IE - Irlanda 331
UA - Ucraina 317
IN - India 278
JP - Giappone 262
GB - Regno Unito 258
NL - Olanda 239
CA - Canada 216
BD - Bangladesh 172
MX - Messico 146
SE - Svezia 106
PL - Polonia 99
AR - Argentina 86
PH - Filippine 86
AU - Australia 78
KR - Corea 77
ES - Italia 75
ID - Indonesia 75
ZA - Sudafrica 74
IQ - Iraq 70
TR - Turchia 67
CI - Costa d'Avorio 66
TH - Thailandia 54
PK - Pakistan 51
EC - Ecuador 47
TW - Taiwan 43
SA - Arabia Saudita 37
AT - Austria 34
CO - Colombia 27
BE - Belgio 26
RO - Romania 26
LT - Lituania 24
MA - Marocco 24
VE - Venezuela 24
UZ - Uzbekistan 22
EG - Egitto 21
ET - Etiopia 20
JM - Giamaica 18
MY - Malesia 18
NP - Nepal 18
TN - Tunisia 18
CZ - Repubblica Ceca 16
GR - Grecia 16
IL - Israele 16
JO - Giordania 16
KE - Kenya 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
PT - Portogallo 14
CL - Cile 13
TT - Trinidad e Tobago 13
PE - Perù 12
PY - Paraguay 12
AZ - Azerbaigian 11
NZ - Nuova Zelanda 11
RS - Serbia 11
IR - Iran 10
LB - Libano 10
CR - Costa Rica 9
OM - Oman 9
UY - Uruguay 9
EU - Europa 8
CH - Svizzera 7
HR - Croazia 7
PA - Panama 7
DO - Repubblica Dominicana 6
HN - Honduras 6
KZ - Kazakistan 6
MD - Moldavia 6
SN - Senegal 6
BO - Bolivia 5
BY - Bielorussia 5
MT - Malta 5
NI - Nicaragua 5
PR - Porto Rico 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BB - Barbados 4
DK - Danimarca 4
GA - Gabon 4
LK - Sri Lanka 4
MK - Macedonia 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
GT - Guatemala 3
LU - Lussemburgo 3
MN - Mongolia 3
Totale 30.409
Salva come PNG Salva come JPEG
Città #
Singapore 2.246
San Jose 1.322
Hong Kong 848
Chandler 739
Moscow 735
Ashburn 615
Beijing 570
Ho Chi Minh City 498
Hanoi 439
Santa Clara 422
Naples 346
Jacksonville 315
Hefei 280
Millbury 263
The Dalles 258
Los Angeles 256
Lauterbourg 250
Tokyo 227
Princeton 206
Napoli 203
New York 175
Nanjing 169
Council Bluffs 167
Dong Ket 156
Amsterdam 151
Munich 147
Boston 142
Buffalo 132
Dallas 114
Rome 114
Wilmington 106
São Paulo 100
Dearborn 98
Des Moines 83
Houston 77
Milan 75
Warsaw 75
Redondo Beach 73
Da Nang 72
Frankfurt am Main 71
Seattle 67
Mexico City 65
Orem 65
Menlo Park 64
Ottawa 64
Denver 59
Turku 58
Woodbridge 57
Haiphong 56
London 55
Nanchang 52
Hebei 49
Lappeenranta 49
Seoul 49
Atlanta 47
Chennai 47
Montreal 47
Mumbai 47
Dublin 46
Helsinki 44
Shenyang 44
Nuremberg 41
Brooklyn 40
Chicago 39
Boardman 38
Tianjin 37
Kronberg 36
Lawrence 36
Phoenix 36
Falkenstein 34
Hải Dương 34
Stockholm 34
Poplar 32
Toronto 32
Redwood City 31
Bangkok 30
Johannesburg 30
Changsha 29
Rio de Janeiro 29
Melbourne 28
Baghdad 27
Falls Church 27
Jakarta 26
Quito 26
Shanghai 26
Guangzhou 25
Pune 25
San Francisco 25
Norwalk 24
Belo Horizonte 23
Can Tho 23
Jiaxing 23
Biên Hòa 22
Curitiba 22
Palermo 22
Dhaka 20
Manchester 20
Thái Nguyên 20
Addis Ababa 19
Bologna 19
Totale 15.576
Salva come PNG Salva come JPEG
Nome #
Effects of oral supplementation with the symbiotic (bifidobacterium longum w11 + fos actilight) on IBS with constipation: a randomized, dose finding trial, versus fibers, 597
La dispepsia post-infettiva: evoluzione sintomatologica- funzionale, predisposizione genetica, ruolo dell'Ossido Nitrico Sintetasi inducibile e coinvolgimento della glia entererica. 358
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 335
The potential of cannabidiol in the COVID‐19 pandemic. 244
ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS 227
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients 224
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 224
Effect of carbonated drinks on upper digestive tract sensations and physiology in healthy subjects. 215
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 201
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 197
Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study 191
Clinical and nutritional correlates associated with weight changes in achalasia patients and the impact of laparoscopic Heller myotomy 178
Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice 168
Enteric Glia Stimulates Inflammation-Induced Responses in Human Intestine and Interacts with Immune Cells via S100B Protein 168
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects ofL. casei DG® (Lactobacillus paracaseiCNCM I-1572) 164
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 163
The astroglial-derived S100 Beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. 160
Altered taste perception in patients with gastroesophagealreflux disease 160
Nasogastric tube after laparoscopic Heller-Dor surgery: Do you really need it? 159
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 159
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 157
Preservation of the inferior mesenteric artery VS ligation of the inferior mesenteric artery in left colectomy: evaluation of functional outcomes-a prospective non-randomized controlled trial 155
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index 155
Long-Term Functional Results of a Modified Caudal-to-Cranial Approach in Laparoscopic Segmental Left Colectomy for Diverticular Disease 154
Probiotic and Postbiotic Effects of Lactobacillus Casei DG on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies 153
Eosinophilic esophagitis: From pathophysiology to treatment. 152
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 151
Mild dehydration in dyspeptic athletes is able to increase gastrointestinal symptoms: Protective effects of an appropriate hydration 151
Impaired duodenal Palmitoylethanolamide release underlies acid-induced mast cells activation in Functional Dyspepsia 150
Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis 149
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 149
Impact of psychological distress and psychophysical wellbeing on posttraumatic symptoms in parents of preterm infants after NICU discharge 148
Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases 148
Endoscopic treatment of esophageal achalasia 147
S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. 146
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 146
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 146
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 145
TASTE DISORDERS IN PATIENTS WITH GASTROESOPHAGEALREFLUX DISEASE 144
PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE 144
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 144
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 142
Next-Generation Probiotics for Inflammatory Bowel Disease 141
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 141
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 141
Acetonic Extract from the Feijoa sellowiana Berg. Fruit Exerts Antioxidant Properties and Modulates Disaccharidases Activities in Human Intestinal Epithelial Cells 140
Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives 139
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 138
Effect of Dewaxed Coffee on Gastroesophageal Symptoms in Patients with GERD: A Randomized Pilot Study 138
Effect of enteroglial-derived S100B protein on human peripheral and mucosal immune cells’ functions 137
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 136
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 136
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 136
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 135
Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults 135
La proteina di derivazione enterogliale S100B stimola la produzione di ossido nitrico nella colite ulcerosa. 134
Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic 134
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 133
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 132
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 132
Enteric Glial Protein S100b Up-Regulation Stimulates Nitric Oxide Production in Ulcerative Colitis. 131
CO2 modulates the central neural processing of sweet perception: an fMRI study 131
6 months-treatment of symptomatic uncomplicated diverticular disease of the colon with Lactobacillus paracasei F19 130
Effect of enteroglial-derived S100B protein on proliferation and responses in human peripheral and mucosal immune cells 130
THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE 130
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 130
Enteric glia: A new player in inflammatory bowel diseases 130
Author's reply: “Nutritional evaluations and post-treatment strategies in Achalasia” 129
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 129
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 129
Cortical representation of different taste modalities on the gustatory cortex: A pilot study 129
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 129
Autoimmune comorbidities in idiopathic achalasia 128
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease 128
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 127
Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome 127
Laparoscopic Heller-Dor myotomy in elderly achalasia patients: a single center experience with PSM analysis 127
Esophageal Acid Exposure and Altered Neurocardiac Function in Patients with GERD and Idiopatic Cardiac Arrhythmias 127
Genetic contribution to motility disorders of the upper gastrointestinal tract. 126
S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells 125
Proton pump inhibitors prescribing following the introduction of generic drugs 125
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 124
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 124
Association between ccttt pentanucleotide repeat in the inducible nitric oxide synthase promoter polymorphism and achalasia 123
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 123
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2 123
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 123
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice 122
PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI) 122
Irritable bowel syndrome and food interaction. 122
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 121
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 121
THE ENTEROGLIAL-DERIVED S100B PROTEIN CONTROLSHUMAN INTESTINAL EPITHELIAL CELLS DIFFERENTIATION ANDPROLIFERATION VIA RAGE INTERACTION 121
Phytotherapics in COVID19: Why palmitoylethanolamide? 121
Gastric determinants of maximum satiety induced by standardized solid and liquid meal. An MRI study in non obese healthy subjects 120
Role of Human Enteroglial Cells in Mediating Pathogenic and Probiotic Bacteria Effects on Intestinal Epithelial Cells 120
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us? 119
PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS 119
Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients 119
Robotic Surgery and Functional Esophageal Disorders: A Systematic Review and Meta-Analysis 118
Totale 15.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 0 0 164
2021/20221.446 12 18 5 18 23 72 24 43 271 82 323 555
2022/20231.729 264 148 45 127 204 208 25 156 263 148 109 32
2023/20241.604 48 191 189 143 71 119 74 173 70 92 264 170
2024/20257.520 402 467 59 92 241 454 725 471 649 762 2.559 639
2025/202615.076 1.635 934 1.373 1.534 2.434 660 1.642 1.061 1.882 1.195 600 126
Totale 30.974